Issue 17, 2025

Hypoxia-responsive bilirubin supramolecular nanoprodrugs for targeted photothermal-chemotherapy

Abstract

A bilirubin supramolecular nanoprodrug (SCBR/TPZ) with enhanced cellular uptake towards the HepG2 cell line was constructed based on host–guest recognition, which provided an innovative strategy to design a hypoxia-responsive BR supramolecular nanoprodrug for lactose-targeted photothermal-chemotherapy (PTT-CT) with a synergistic effect towards HepG2.

Graphical abstract: Hypoxia-responsive bilirubin supramolecular nanoprodrugs for targeted photothermal-chemotherapy

Supplementary files

Article information

Article type
Communication
Submitted
05 Dec 2024
Accepted
29 Jan 2025
First published
29 Jan 2025

Chem. Commun., 2025,61, 3512-3515

Hypoxia-responsive bilirubin supramolecular nanoprodrugs for targeted photothermal-chemotherapy

Y. Xie, L. Zheng, T. Chen and Y. Ding, Chem. Commun., 2025, 61, 3512 DOI: 10.1039/D4CC06433J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements